NRF2 mitigates radiation-induced hematopoietic death
- PMID: 24569364
- PMCID: PMC3938265
- DOI: 10.1172/JCI74143
NRF2 mitigates radiation-induced hematopoietic death
Abstract
Fractionated, high-dose total body irradiation (TBI) is used therapeutically to myeloablate and immune suppress patients undergoing hematopoietic stem cell (HSC) transplantation. Acute exposure to ionizing radiation can have fatal effects on the hematopoietic and immune systems. Currently, therapies aimed at ameliorating ionizing radiation-associated toxicities are limited. In the February 2014 issue of the JCI, Kim and colleagues demonstrated that induction of nuclear factor erythroid 2-related factor 2 (NRF2) enhances HSC regeneration and increases survival following ionizing radiation exposure in mice. The results of this study suggest that NRF2 is a novel potential target for the development of therapeutics aimed at mitigating the toxicities of ionizing radiation exposure.
Comment on
-
NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.J Clin Invest. 2014 Feb;124(2):730-41. doi: 10.1172/JCI70812. Epub 2014 Jan 27. J Clin Invest. 2014. PMID: 24463449 Free PMC article.
References
-
- Till J, McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 2012;178(2):AV3–AV7. - PubMed
-
- Hiroshima Day Committee. Hiroshima and Nagasaki Bombing: Facts about the atomic bomb. Hiroshima Day Committee Web site. http://www.hiroshimacommittee.org/Facts_NagasakiAndHiroshimaBombing.htm . Accessed January 24, 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical